CVS Group Plc, a leading provider of integrated veterinary services in the UK, recently announced the exercise of options over a total of 41,174 ordinary shares of 0.2 pence each. These options were exercised under the CVS Group 2020 SAYE Plan at an exercise price of £10.09. The issuance of shares in connection with the exercise was fully satisfied by shares held by the CVS Group Employee Benefit Trust. Following the exercise, a total of 6,771 Ordinary Shares are held by the EBT, representing approximately 0.009% of the Company's total voting rights.

Richard Fairman, the Chief Executive Officer, exercised options over 606 Ordinary Shares in the Company. The remaining options were exercised by certain other employees and former employees of the Company. Following his option exercise, Richard Fairman, along with any persons closely associated, holds a beneficial interest in 78,107 Ordinary Shares in the Company, representing approximately 0.109% of the total voting rights of the Company.

The notification provided further details in accordance with the requirements of the UK Market Abuse Regulation. The company's contacts were also listed, including CVS Group plc, Peel Hunt LLP, Berenberg, and Camarco.

The notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them were also included in the announcement. This included details of the person discharging managerial responsibilities, the reason for the notification, details of the issuer, and details of the transaction(s).

The exercise of SAYE options and PDMR dealing by CVS Group Plc demonstrates the company's commitment to its employees and the transparency in its financial transactions.